A142280 Stock Overview
Manufactures and sells diagnostic reagents and medical devices in South Korea and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Green Cross Medical Science Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩3,505.00 |
| 52 Week High | ₩6,950.00 |
| 52 Week Low | ₩3,090.00 |
| Beta | 0.46 |
| 1 Month Change | -5.91% |
| 3 Month Change | -15.54% |
| 1 Year Change | -26.52% |
| 3 Year Change | -51.52% |
| 5 Year Change | -33.49% |
| Change since IPO | -66.14% |
Recent News & Updates
Is Green Cross Medical Science (KOSDAQ:142280) A Risky Investment?
Aug 30
There's No Escaping Green Cross Medical Science Corporation's (KOSDAQ:142280) Muted Revenues Despite A 45% Share Price Rise
Aug 08Recent updates
Is Green Cross Medical Science (KOSDAQ:142280) A Risky Investment?
Aug 30There's No Escaping Green Cross Medical Science Corporation's (KOSDAQ:142280) Muted Revenues Despite A 45% Share Price Rise
Aug 08We Think Green Cross Medical Science's (KOSDAQ:142280) Solid Earnings Are Understated
Mar 26Investors Shouldn't Be Too Comfortable With Green Cross Medical Science's (KOSDAQ:142280) Robust Earnings
Mar 23These 4 Measures Indicate That Green Cross Medical Science (KOSDAQ:142280) Is Using Debt Extensively
Feb 24Is Green Cross Medical Science's (KOSDAQ:142280) Share Price Gain Of 128% Well Earned?
Jan 28Is Green Cross Medical Science Corporation (KOSDAQ:142280) Popular Amongst Insiders?
Jan 02Should We Be Excited About The Trends Of Returns At Green Cross Medical Science (KOSDAQ:142280)?
Dec 07Shareholder Returns
| A142280 | KR Medical Equipment | KR Market | |
|---|---|---|---|
| 7D | -4.9% | -3.7% | -1.9% |
| 1Y | -26.5% | -4.3% | -9.5% |
Return vs Industry: A142280 underperformed the KR Medical Equipment industry which returned -4.3% over the past year.
Return vs Market: A142280 underperformed the KR Market which returned -9.5% over the past year.
Price Volatility
| A142280 volatility | |
|---|---|
| A142280 Average Weekly Movement | 6.0% |
| Medical Equipment Industry Average Movement | 7.6% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in KR Market | 12.8% |
| 10% least volatile stocks in KR Market | 3.3% |
Stable Share Price: A142280 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A142280's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1972 | 128 | n/a | www.greencrossms.com |
Green Cross Medical Science Corporation manufactures and sells diagnostic reagents and medical devices in South Korea and internationally. The company offers immunology diagnostic reagents. It also provides COVID-19 kit; blood glucose monitoring system; HbA1c test machine; and Gcare LIPID and LIPID printer.
Green Cross Medical Science Corporation Fundamentals Summary
| A142280 fundamental statistics | |
|---|---|
| Market cap | ₩76.08b |
| Earnings (TTM) | ₩150.14m |
| Revenue (TTM) | ₩99.72b |
506.8x
P/E Ratio0.8x
P/S RatioIs A142280 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A142280 income statement (TTM) | |
|---|---|
| Revenue | ₩99.72b |
| Cost of Revenue | ₩86.04b |
| Gross Profit | ₩13.68b |
| Other Expenses | ₩13.53b |
| Earnings | ₩150.14m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 6.92 |
| Gross Margin | 13.72% |
| Net Profit Margin | 0.15% |
| Debt/Equity Ratio | 45.6% |
How did A142280 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/26 03:17 |
| End of Day Share Price | 2024/12/26 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Green Cross Medical Science Corporation is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jiyong Lee | Shinhan Investment Corp. |